Literature DB >> 32090369

Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions.

Zhu Xian Zhang1, Ewoudt M W van de Garde1,2, Maaike Söhne3, Ankie M Harmsze1, Marcel P H van den Broek1.   

Abstract

AIMS: Even though the use of direct oral anticoagulants (DOACs) is safe based on clinical outcomes, drug safety also depends on appropriateness of drug prescription, which is challenging for DOACs since many patient factors need to be considered. The aim of this study was to assess the appropriateness of DOAC prescriptions and to identify risk factors of determinants for inappropriate DOAC prescriptions.
METHODS: A retrospective study in a nonuniversity teaching hospital was performed of hospitalized patients (≥18 years) who received an initial DOAC prescription between February and August 2018. Appropriateness of prescribing was evaluated on 8 criteria by using a modified version of the medication appropriateness index.
RESULTS: A total of 770 initial DOAC prescriptions of inpatients were evaluated: 267 patients (34.6%) had at least met 1 inappropriate criterion for a DOAC prescription. The most frequent inappropriate criterion was dosage (17.4%). Of the 4 DOACs, dabigatran (21.6%) and apixaban (21.2%) were mostly inappropriate dosed. In a multivariable analysis, reduced renal function (estimated glomerular filtration rate <50 mL/min; odds ratio [OR] = 2.35; P < .001), a diagnosis of atrial fibrillation (OR = 1.87; P = .004), and 'prescribed by surgeons' (OR = 1.9; P = .013) were independently associated with inappropriateness of prescribing.
CONCLUSION: This study has highlighted a high degree of inappropriate prescribing of DOACs. These results underline the need for targeted interventions to improve DOAC prescribing.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  DOAC; appropriateness of prescription; medication appropriateness index; medication errors; prescribing patterns

Mesh:

Substances:

Year:  2020        PMID: 32090369      PMCID: PMC7373716          DOI: 10.1111/bcp.14264

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  27 in total

1.  Medication appropriateness index: reliability and recommendations for future use.

Authors:  Anne Spinewine; Christophe Dumont; Louise Mallet; Christian Swine
Journal:  J Am Geriatr Soc       Date:  2006-04       Impact factor: 5.562

2.  Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry.

Authors:  Martín Ruiz Ortiz; Javier Muñiz; Paula Raña Míguez; Inmaculada Roldán; Francisco Marín; María Asunción Esteve-Pastor; Angel Cequier; Manuel Martínez-Sellés; Vicente Bertomeu; Manuel Anguita
Journal:  Europace       Date:  2018-10-01       Impact factor: 5.214

3.  PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study).

Authors:  Ozcan Basaran; Nesrin Filiz Basaran; Edip Guvenc Cekic; Ibrahim Altun; Volkan Dogan; Gurbet Ozge Mert; Kadir Ugur Mert; Fatih Akin; Mustafa Ozcan Soylu; Kadriye Memic Sancar; Murat Biteker
Journal:  Clin Appl Thromb Hemost       Date:  2015-10-30       Impact factor: 2.389

4.  New oral anticoagulants: appropriateness of prescribing in real-world setting.

Authors:  C S Pattullo; M Barras; B Tai; M McKean; P Donovan
Journal:  Intern Med J       Date:  2016-07       Impact factor: 2.048

Review 5.  Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.

Authors:  C Chai-Adisaksopha; C Hillis; T Isayama; W Lim; A Iorio; M Crowther
Journal:  J Thromb Haemost       Date:  2015-10-05       Impact factor: 5.824

6.  Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants.

Authors:  Molly Howard; Andrew Lipshutz; Breanne Roess; Emily Hawes; Zachariah Deyo; Jena Ivey Burkhart; Stephan Moll; Betsy Bryant Shilliday
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

7.  Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions.

Authors:  Zhu Xian Zhang; Ewoudt M W van de Garde; Maaike Söhne; Ankie M Harmsze; Marcel P H van den Broek
Journal:  Br J Clin Pharmacol       Date:  2020-03-13       Impact factor: 4.335

8.  Effect of Renal Function on Dosing of Non-Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation.

Authors:  Sulena Shrestha; Onur Baser; Winghan Jacqueline Kwong
Journal:  Ann Pharmacother       Date:  2017-08-31       Impact factor: 3.154

9.  Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.

Authors:  Naoual Bennaghmouch; Anne J W M de Veer; Kerstin Bode; Bakhtawar K Mahmoodi; Willem J M Dewilde; Gregory Y H Lip; Martina Brueckmann; Eva Kleine; Jurriën M Ten Berg
Journal:  Circulation       Date:  2017-11-03       Impact factor: 29.690

10.  Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program.

Authors:  Amichai Perlman; Ehud Horwitz; Bruria Hirsh-Raccah; Gefen Aldouby-Bier; Tamar Fisher Negev; Sarit Hochberg-Klein; Yosef Kalish; Mordechai Muszkat
Journal:  Isr J Health Policy Res       Date:  2019-02-01
View more
  3 in total

1.  Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions.

Authors:  Zhu Xian Zhang; Ewoudt M W van de Garde; Maaike Söhne; Ankie M Harmsze; Marcel P H van den Broek
Journal:  Br J Clin Pharmacol       Date:  2020-03-13       Impact factor: 4.335

2.  Choice of oral anticoagulant prescribed by general practices in Wales: Application of Dirichlet regression and linked data.

Authors:  Daniel Hill-McManus; Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2022-01-25       Impact factor: 3.716

3.  Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription.

Authors:  Maral Koolian; Daniel Wiseman; Helen Mantzanis; Nikki Kampouris; Ryan S Kerzner; Susan R Kahn
Journal:  Res Pract Thromb Haemost       Date:  2022-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.